Cargando…
Splicing factor TRA2A contributes to esophageal cancer progression via a noncanonical role in lncRNA m(6)A methylation
Transformer 2 alpha homolog (TRA2A), a member of the serine/arginine‐rich splicing factor family, has been shown to control mRNA splicing in development and cancers. However, it remains unclear whether TRA2A is involved in lncRNA regulation. In the present study, we found that TRA2A was upregulated...
Autores principales: | Bei, Mingrong, Hao, Shijia, Lin, Kai, Chen, Qiuyang, Cai, Yujie, Zhao, Xing, Jiang, Leiming, Lin, Lirui, Dong, Geng, Xu, Jianzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394134/ https://www.ncbi.nlm.nih.gov/pubmed/37317053 http://dx.doi.org/10.1111/cas.15870 |
Ejemplares similares
-
TRA2A Binds With LncRNA MALAT1 To Promote Esophageal Cancer Progression By Regulating EZH2/β-catenin Pathway
por: Zhao, Xing, et al.
Publicado: (2021) -
Characterizing the tumor RBP-ncRNA circuits by integrating transcriptomics, interactomics and clinical data
por: Jiang, Leiming, et al.
Publicado: (2021) -
Unraveling the therapeutic potential of the LncRNA-dependent noncanonical Hedgehog pathway in cancer
por: Xing, Zhen, et al.
Publicado: (2015) -
The splicing regulators Tra and Tra2 are unusually potent activators of pre-mRNA splicing
por: Sciabica, Kathryn S., et al.
Publicado: (2006) -
CRIT: Identifying RNA-binding protein regulator in circRNA life cycle via non-negative matrix factorization
por: Shao, Mengting, et al.
Publicado: (2022)